Bayer AG
XETRA:BAYN
Bayer AG
Other Current Assets
Bayer AG
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Other Current Assets
€51m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Other Current Assets
$2.3m
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Other Current Assets
€694m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
MPH Health Care AG
XETRA:93M1
|
Other Current Assets
€10.9k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Other Current Assets
€56.2m
|
CAGR 3-Years
58%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Other Current Assets
€2.3m
|
CAGR 3-Years
183%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Other Current Assets?
Other Current Assets
51m
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Other Current Assets amounts to 51m EUR.
What is Bayer AG's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-26%
Over the last year, the Other Current Assets growth was 1 600%. The average annual Other Current Assets growth rates for Bayer AG have been -23% over the past three years , -26% over the past five years .